348 related articles for article (PubMed ID: 23711220)
41. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps.
Pratesi F; Dioni I; Tommasi C; Alcaro MC; Paolini I; Barbetti F; Boscaro F; Panza F; Puxeddu I; Rovero P; Migliorini P
Ann Rheum Dis; 2014 Jul; 73(7):1414-22. PubMed ID: 23727635
[TBL] [Abstract][Full Text] [Related]
42. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
Front Immunol; 2018; 9():3033. PubMed ID: 30662440
[TBL] [Abstract][Full Text] [Related]
43. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.
Fisher BA; Bang SY; Chowdhury M; Lee HS; Kim JH; Charles P; Venables P; Bae SC
Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239
[TBL] [Abstract][Full Text] [Related]
44. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
[TBL] [Abstract][Full Text] [Related]
45. The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis.
Liang B; Ge C; Lönnblom E; Lin X; Feng H; Xiao L; Bai J; Ayoglu B; Nilsson P; Nandakumar KS; Zhao M; Holmdahl R
Rheumatology (Oxford); 2019 Sep; 58(9):1623-1633. PubMed ID: 30892636
[TBL] [Abstract][Full Text] [Related]
46. IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.
Barakat S; Meyer O; Torterotot F; Youinou P; Briand JP; Kahn MF; Muller S
Clin Exp Immunol; 1992 Jul; 89(1):38-45. PubMed ID: 1378364
[TBL] [Abstract][Full Text] [Related]
47. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies.
Pratesi F; Tommasi C; Anzilotti C; Puxeddu I; Sardano E; Di Colo G; Migliorini P
Clin Exp Immunol; 2011 Jun; 164(3):337-45. PubMed ID: 21413944
[TBL] [Abstract][Full Text] [Related]
48. Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis.
Johansson L; Pratesi F; Brink M; Ärlestig L; D'Amato C; Bartaloni D; Migliorini P; Rantapää-Dahlqvist S
Arthritis Res Ther; 2016 Jun; 18(1):127. PubMed ID: 27255888
[TBL] [Abstract][Full Text] [Related]
49. Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.
Titcombe PJ; Wigerblad G; Sippl N; Zhang N; Shmagel AK; Sahlström P; Zhang Y; Barsness LO; Ghodke-Puranik Y; Baharpoor A; Hansson M; Israelsson L; Skriner K; Niewold TB; Klareskog L; Svensson CI; Amara K; Malmström V; Mueller DL
Arthritis Rheumatol; 2018 Dec; 70(12):1933-1945. PubMed ID: 29927106
[TBL] [Abstract][Full Text] [Related]
50. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
[TBL] [Abstract][Full Text] [Related]
51. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
[TBL] [Abstract][Full Text] [Related]
52. Production of autoantibodies against citrullinated antigens/peptides by human B cells.
Bellatin MF; Han M; Fallena M; Fan L; Xia D; Olsen N; Branch V; Karp D; Stastny P
J Immunol; 2012 Apr; 188(7):3542-50. PubMed ID: 22345652
[TBL] [Abstract][Full Text] [Related]
53. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides.
Scinocca M; Bell DA; Racapé M; Joseph R; Shaw G; McCormick JK; Gladman DD; Pope J; Barra L; Cairns E
J Rheumatol; 2014 Feb; 41(2):270-9. PubMed ID: 24429169
[TBL] [Abstract][Full Text] [Related]
54. Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.
Terzoglou AG; Routsias JG; Avrameas S; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2006 Jun; 144(3):432-9. PubMed ID: 16734612
[TBL] [Abstract][Full Text] [Related]
55. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
[TBL] [Abstract][Full Text] [Related]
56. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?
Balandraud N; Auger I; Roudier J
J Autoimmun; 2021 Jan; 116():102542. PubMed ID: 32928608
[TBL] [Abstract][Full Text] [Related]
57. Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.
Hansson M; Mathsson L; Schlederer T; Israelsson L; Matsson P; Nogueira L; Jakobsson PJ; Lundberg K; Malmström V; Serre G; Holmdahl R; Nystrand M; Klareskog L; Rönnelid J
Arthritis Res Ther; 2012 Oct; 14(5):R201. PubMed ID: 23025688
[TBL] [Abstract][Full Text] [Related]
58. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
[TBL] [Abstract][Full Text] [Related]
59. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
[TBL] [Abstract][Full Text] [Related]
60. Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition.
Fanelli I; Rovero P; Hansen PR; Frederiksen J; Houen G; Trier NH
Antibodies (Basel); 2021 Jul; 10(3):. PubMed ID: 34449533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
